Genomics and Digital Health Frontiers Science Series at Biotech Campus 2025-2026
Genomics and Digital Health Frontiers Science Series are in the program "Genomics and Digital Health" of the doctoral school in "Life Sciences from the Faculties of Medicine and Science" and are open to all programs of the PhD school of Life Science, and external participants. It is taught by PIs participating in the program and several external teachers. It will cover a wide range of selected topics in Digital Health and Data Science for Digital Health..
- Digital Health (DH)
- Genomics
- Methodology in Research
- Ethical and Security Issues in DH
- Semantics and Interoperability
- Computational biomedical sciences
- Natural Language Processing in Health
- Health Data Analytics
- Machine Learning in Health
- Health Data Representation
- Biomedical Signal Processing
- Public Health
- Community Health
On Wednesdays from 11am to 12pm
Room H8-01-D or H8-01-F or H4-02-A (Biotech Campus)
Zoom access https://unige.zoom.us/j/61223662192?pwd=ou7OHlnG6eUNFAluhUeAwgQrR0RlHl.1
More info here
September 10th in H4-02-A Lucille Delisle (UNIGE) baredSC: Bayesian approach to retrieve expression distribution of single-cell data
Bioinformatics analysis of NGS data in the groups of Prof Herrara and Prof. Andrey, Department of Genetic Medicine and Development
October 1th in H8-01-F - Stéphane Meystre (SUPSI) LLMs are (still) not ready for clinical data
Prof. Stéphane Meystre is a physician and biomedical informaticist, expert in applications of AI and more specifically machine learning and natural language processing (NLP) to support more effective clinical care and enable reuse of existing clinical information for precision health and research applications, all while addressing responsible AI requirements. Dr. Meystre is (full) Professor of Biomedical Informatics and Director of the new Institute of Digital Technologies for Personalised Healthcare (MeDiTech) at SUPSI's Department of Innovative Technologies in Lugano, Switzerland.
November 5th in H4-02-A - Timothée Olivier (HUG) Real-World Data in Oncology: challenges and opportunities
Dr. Timothée Olivier is a Swiss oncologist practicing at the Oncology Department of the Geneva University Hospitals and a Privat-Docent at the University of Geneva. He is internationally recognized for his expertise in evidence-based medicine and clinical trial methodology. Dr. Olivier trained at the University of California, San Francisco (UCSF) under Professor Vinay Prasad, who now holds a senior position at the U.S. Food and Drug Administration.
December 3 H8-01-F Pablo Jané Soler (HUG/UNIGE) The Imageable Genome
Dr. Pablo Jané is a board-certified nuclear medicine physician at Geneva University Hospitals (HUG) and a former Visiting Fellow at Clare Hall, University of Cambridge. His work focuses on oncology, AI and theranostics, and he’s published in Nature Communications as lead/co-author on “The Imageable Genome” and “The Theranostic Genome”.
January 7th - Christophe Gaudet-Blavignac (HUG/UNIGE) H4-02-A
February 4th - Douglas Teodoro (UNIGE) H4-02-A
March 5th - Jean-Louis Raisaro (CHUV) H4-02-A
April 1st - Margarita Liarou (CUI/UNIGE) H4-02-A
May 6th - Jérôme Schmid (HEdS) H4-02-A
June 10th - Janna Hastings (UZH) H4-02-A